Autoantibodies against zinc transporter 8 further stratify the autoantibody‐defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study
Authors:
- 16 August 2020
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 38 (2) , e14389
Abstract
Aims: To evaluate the diagnostic relevance of autoantibodies against zinc transporter 8 (ZnT8) in schoolchildren from the general population as well as in people with autoimmune diabetes.Methods: A total of 137 schoolchildren positive for at least one of the three major diabetes‐associated autoantibodies, without diabetes heredity or preselection on HLA typing, from the Karlsburg Type 1 Diabetes Risk Study, as well as 102 people at type 1 diabetes onset, 88 people with latent autoimmune diabetes in adults and 119 people with type 2 diabetes, were analysed for different ZnT8 autoantibody variants.Results: Zinc transporter 8 autoantibody positivity was found in 18% of autoantibody‐positive schoolchildren, with a noticeable association with other autoantibodies associated with type 1 diabetes and disease progression. Furthermore, ZnT8 autoantibody positivity was associated with diabetes progression in schoolchildren positive for autoantibodies against insulinoma‐associated antigen‐2 (IA‐2) and, importantly, in seven IA‐2 autoantibody‐negative schoolchildren. Additionally, ZnT8 autoantibodies were found in 56% of people with type 1 diabetes, predominantly directed against all three ZnT8 variants and comparable to schoolchildren with multiple autoantibodies. In contrast, ZnT8 autoantibodies were detected in 10% of people with latent autoimmune diabetes in adults, none of them with reactivity to all three isoforms.Conclusion: Zinc transporter 8 autoantibodies are useful markers for prediction of type 1 diabetes in a general population, further stratifying the risk of progression in autoantibody‐positive children. ZnT8 autoantibodies are also important markers in adult‐onset diabetes, with a completely different reaction pattern in type 1 diabetes in comparison to latent autoimmune diabetes in adults, and may therefore help to differentiate between the two forms.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung
- Diabetes-Stiftung
- Bundesministerium für Forschung und Technologie (01KS9601)
- Deutsche Forschungsgemeinschaft (SFB263)
This publication has 30 references indexed in Scilit:
- Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive childrenDiabetologia, 2013
- Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at DiagnosisDiabetes, 2012
- Prediction and prevention of Type 1 diabetes mellitusJournal of Diabetes, 2011
- Kinetics of the Post-Onset Decline in Zinc Transporter 8 Autoantibodies in Type 1 Diabetic Human SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2010
- ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onsetAutoimmunity, 2010
- Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune DiabetesDiabetes Care, 2009
- A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 DiabetesDiabetes, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- Prevalence of Diabetes-Associated Autoantibodies in Schoolchildren: The Karlsburg Type 1 Diabetes Risk StudyAnnals of the New York Academy of Sciences, 2004
- The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of -Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive IndividualsThe Journal of Clinical Endocrinology & Metabolism, 2002